Completed PHASE2 INTERVENTIONAL 2-arm NCT02569866

Antibiotics After Breast Reduction:Clinical Trial With Randomization

Sponsor: Federal University of São Paulo

Updated 5 times since 2017 Last updated: Apr 18, 2018 Started: Nov 30, 2014 Primary completion: May 31, 2016 Completion: Aug 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Surgical Site Infection and is currently completed. Federal University of São Paulo leads this study, which shows 5 recorded versions since 2014 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Nov 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Federal University of São Paulo
Universidade do Vale do Sapucai

Data source: Federal University of São Paulo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pouso Alegre, Brazil